Results for tag: "Dexmedetomidine"

Dexmedetomidine is a selective alpha-2 agonist used as an anesthetic drug. It is used to provide sedation and analgesia during medical procedures, and to reduce the need for anesthetics. It is also used to reduce the risk of delirium in intensive care unit (ICU) patients. Dexmedetomidine is administered intravenously or intramuscularly, and is available in both generic and branded formulations. It is typically used in combination with other anesthetic drugs, such as propofol, midazolam, and fentanyl. Dexmedetomidine has been shown to reduce the need for anesthetics, reduce the risk of delirium in ICU patients, and reduce the risk of postoperative nausea and vomiting. It is also used to reduce the risk of postoperative pain and to reduce the risk of postoperative cognitive dysfunction. The dexmedetomidine market is growing due to its increasing use in medical procedures and its potential to reduce the need for anesthetics. The market is expected to continue to grow as more medical procedures are performed and more patients are treated with dexmedetomidine. Some companies in the dexmedetomidine market include Hospira, Mylan, Teva Pharmaceuticals, and Fresenius Kabi. Show Less Read more